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Abstract
We introduce a new experimental approach to measuring the effects of health insurance pol-
icy alternatives on behavior and health outcomes over the life course. Cash-motivated subjects
are placed in a virtual environment where they earn income and allocate it across multi-period
lives. We compare behavior across age, income and insurance plans—one priced according to an
individual’s expected cost and the other uniformly priced through employer-implemented cost
sharing. We find that 1) subject behavior approximated optimal responses; 2) in all treatments,
subjects under-invested in health early in life and over-invested in health late in life; 3) subjects
in the employer-implemented plan purchased insurance at higher rates; 4) the employer-based
plan reduced differences due to income and age; 5) subjects in the actuarial plan engaged in
more health-promoting behaviors, but still below optimal levels, and did save at the level re-
quired, so did realize the full benefits of the plan. Contrary, to model predictions, the actuarial
priced insurance plan did not increase utility relative to the employer-based plan. Subjects had
more difficulty optimizing choices in the Actuarial treatment’s more dynamic and more compli-
cated decision space.
Keywords; Health insurance, Moral hazard, Inter-generational, Subsidies, Actuarially fair, Employer-
based
1 Introduction
US health care costs consume 17.5% of GDP (CDC, 2018), or nearly 10,000 per person, close to
twice that of other developed nations (OECD, 2017, CMS, 2019a). At the household level, these
costs can result in bankruptcies and other financial hardships (CFPB, 2014). Yet, even with this vast
spending, there are still unmet medical needs. 64% of Americans say that have avoided or delayed
∗Corresponding author: tracy@chapman.edu
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medical care in the last year due to expected costs (20—20 Research, 2018). This combination of
high costs and unmet need have led to on-going debate about healthcare and insurance reform.
Much of the debate regarding health insurance policy concerns individual freedom and respon-
sibility versus universal coverage and reducing health disparities (Moffit et al., 2019). Proponents
of universal coverage argue that it improves the average health of the population, decreases dis-
parities in health outcomes within the population, and generates efficiencies by eliminating the
transactions costs associated with private insurance billing systems. Proponents of systems empha-
sizing individual responsibility argue two points: first, that such plans allow people to exert their
own priorities in health decisions regarding how much and what kind of coverage to purchase; and
second, if insurance premiums and co-pays depend on health behavior, such as smoking, exercise
and diet, people will have incentives to improve their health, reducing the total costs of health care.
There is a growing body of research designed to measure the effects of policy alternatives with
respect to individual responsibility and social cost sharing. One approach is to take advantage of
cross-national data to measure the impacts of health insurance alternatives on patient behavior,
population health and health disparities (NRC, 2010, IOM, 2013). That research shows that health
outcomes in the U.S. have been decreasing in recent decades relative to other developed countries,
who all practice universal cost sharing. However, given that many other nation-level variables co-
vary with insurance policy (NRC, 2010, IOM, 2013), it has been difficult to determine whether
differences in health insurance policies are responsible for the trend and to pinpoint the causes of
the decreasing relative status of the US.
Another approach is to take advantage of ‘natural experiments’ associated with policy changes,
such the Oregon Medicaid Expansion, the SSDI Accelerated Benefits Demonstration Project, Rom-
neyCare and ObamaCare (Weathers and Stegman, 2012, Courtemanche and Zapata, 2014, Finkel-
stein et al., 2015, Lipton and Decker, 2015, Courtemanche et al., 2018, Ghosh et al., 2019). Those
studies confirm that health care usage increases in response to more generous insurance benefits.
They have been less conclusive, however, about the health benefits from the additional spending
and services. There is evidence that self-reported health increases with increased health insur-
ance coverage in Oregon (Baicker and Finkelstein, 2011) and with ‘RomneyCare’ in Massachusetts
(Courtemanche and Zapata, 2014), but effects on objective measures of health were not detected
(see also Weathers and Stegman (2012)) with respect to mortality following the Affordable Care
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Act. The assessment of long term impacts is limited by the fact that all are relatively recent reforms,
in comparison to the decades over which chronic diseases develop.
There is also a rich literature of field experiments offering financial incentives for health pro-
moting behavior. Gine´ et al. (2010) show that financial incentives can promote smoking cessation.
Volpp et al. (2008) show that incentives can induce subjects to lose weight in the short term, but
in the long-term, post-incentive period the weight is regained. Incentives can also be used to in-
crease gym attendance and exercise. The latter are more effective at inducing changes in health
indicators. Again, it is not clear that healthy behaviors are sustained in the post-incentive period.
See Mitchell et al. (2013) and Barte and Wendel-Vos (2017) for systematic reviews. In general,
this research shows financial incentives influence people to adapt healthier behaviors. However,
given their short time frames, such experiments are limited in their ability to measure the effects of
interventions on chronic disease outcomes.
These bodies of research illustrate the methodological challenges in assessing the effects of pol-
icy alternatives with respect to population health and total health care costs. The central challenge
derives from the fact the vast majority of healthcare costs and disease burdens are due to chronic
illnesses, such as heart disease, stroke, diabetes, cancer and dementia. The most important risk
factors for those diseases are directly or indirectly behavioral, such as an obesogenic diet, lack of
physical activity, smoking and drug use. In addition, the effects of behavior accumulate over many
decades, suggesting that full policy impacts may accumulate slowly over time. Another challenge
is that people can prepare for, and prevent, disease events along several different fronts. Exam-
ples are saving money, purchasing health insurance, changing habitual behavior, and engaging in
preventative surveillance and treatment. Since different policies may affect the value of invest-
ing in those fronts, assessing total impacts will require an understanding of potential substitutions
and complements between policies and individual behavior. Because of these challenges, there is
very little causal evidence regarding the impacts of healthcare policy alternatives, despite the very
precise statistics on costs and morbidity and the vigor of the policy debate.
This paper introduces a new, complementary experimental economic approach to address those
challenges in examining the effects of health insurance policy alternatives on behavior and health
outcomes over the life course. This experiment compares two types of premium systems for health
insurance, one based on individual responsibility and the other on cost sharing.
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This paper addresses the following questions with this experimental design. Do differences in
individual responsibility and social cost sharing in health insurance premiums affect: 1) people’s
decisions about whether to purchase insurance; 2) personal investments in health; 3) behaviors
that prevent or increase the risk of adverse health events; 4) savings to buffer the costs of treating
adverse health events; and 5) long-term health outcomes. We also investigate how those effects
vary with income and age to impact disparities in health and behavior.
The paper proceeds as follows. The next section presents detailed descriptions of the theoretical
model motivating the experiment, the experimental environment, and the research design. The fol-
lowing sections presents the theoretical and empirical results, respectively. The theoretical results
show how the optimal time paths of consumption and investments in health vary as a function of
the insurance and income treatments. The empirical section analyzes the treatment effects on sub-
ject behavior and compares their behavior to the theoretically predicted time paths of investments.
The discussion section presents a summary of our main findings and their theoretical implications.
Additionally, it discusses some of the weaknesses in the current design, and appropriate directions
for future research. The conclusion addresses how our approach complements existing approaches.
2 Methods
2.1 Environment and Treatments
Our test environment, based on the Grossman (1972) lifecycle model of health investment, is
designed to model the multiple health-related decisions people make in their daily lives and the
different ways people can prepare for and ameliorate disease events. Subjects live multi-period lives
and have a stock of health that naturally deteriorates each period, and declines further if the subject
suffers a stochastic illness event (Khwaja, 2002), which we call a ‘shock.’ Each period, subjects
receive an income (an allocation of virtual currency) that depends positively on their individual
health (Viscusi and Evans, 1990); this is to capture the idea that health effects the earnings from
work. Subjects must then decide on how to allocate their income to current consumption versus
savings and health-related investments. Health-related investments include the purchase of health
insurance, health recovery from deterioration and shocks, and expenditures on physical fitness,
which we call resilience, that lowers the size of potential future shocks. The ability to invest in
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resilience is designed to capture preventative behaviors such as exercise, diet and abstention from
smoking, drugs, etc. whereas health investment is meant to model services from medical providers,
pharmaceuticals, etc. Shock probability increases in the second half of life to capture the effects of
aging. Insurance pays for recovery from shocks.
The first treatment is actuarially based insurance, in which the cost of each individual subject’s
premium depends on that subject’s expected health care costs to the insurer, which, in turn, depend
on that subject’s age, health state, and health-related behavior. The actuarial plan embodies the
concept of individual responsibility in a competitive insurance marketplace. Each subject chooses
whether or not to purchase insurance given her personal premium. To alleviate the costs of pre-
miums and continuing health degradation, subjects can invest in resilience, save to buffer against
adverse health events, and directly invest in improving current health. The actuarial plan smooths
the lumpy costs of health shocks and provides incentives for individuals to improve their health.
However, it may generate significant inequality in health outcomes, due to variable premium costs
associated with individual conditions.
The second treatment is employer-based insurance, resembling the plans most American have.
Premiums are largely subsidized by the employer (funded through a reduction in wages), and
there is social cost sharing. The premium the employer must pay the insurer is determined by
the average expected costs of all employees who choose the plan. The proportion of the premium
paid directly by the employee is fixed, regardless of age, health state or behavior. The employer
treatment and its incentives differ significantly from the actuarial plan. First, since premiums do
not depend on resilience, there is less incentive to invest in prevention (often referred to as, ‘moral
hazard’). Second, people with greater risk (the ‘old’) would have a greater incentive to purchase
the insurance since their expected health costs would be greater (often referred to as, ‘adverse
selection’). However, this plan is expected to generate less inequality in health outcomes due to
social cost sharing.
Subjects were assigned to one of four experimental treatments groups in a 2x2 experimental
design. One treatment dimension was the actuarial versus employer insurance plan, and the other
was high versus low subject income. In addition, all subjects face a young and an old period during
each life with the latter characterized by higher health risks, so our statistical analysis is necessarily
2x2x2. Payments to subjects were a linear transform of their total lifetime utility, based on their
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health and consumption choices in each period. The challenge subjects faced was to optimize
the allocation of income and previous savings in each period among current consumption, health
repair, investment in resilience, purchase of insurance, and future savings, so as to maximize the
payment they received at the end of the experiment. This framework was chosen to represent the
problem of maximizing the total lifetime utility, subject to income constraints and random shocks
to health.
2.2 Model
This subsection presents the general model employed in our experimental design. We build upon
Grossman (1972) where resources are limited and can be allocated between enjoying life and en-
suring that it continues. Players live for a maximum of T periods. There are two state variables:
health Ht and savings St. Each period, health degrades by a fixed amount δ, and is improved
through an investment of IHt into health. Increasing health allows an individual to be more pro-
ductive, earn greater income and spend less time attending to ailments; thus, income available to
be spent by the player during each period of the experiment is dependent on health. Any income
not invested on health or current consumption is deposited into a savings account available for
future consumption or investments in health. Players derive utility (which we refer to as ‘joy’ in
the subject interface) from investments in joy IJt summed across all periods in life. Joy is a concave
function of dollars invested in consumption, moderated by health, as being healthy allows one to
enjoy life more. Joy is our primary outcome and joy earned determines subjects payouts.
In addition to the standard elements of the Grossman model, we add the prospect of stochastic
negative health shocks, and two additional investments, resilience IRt and insurance I
I
t . Should
a shock occur that period, resilience investment reduces the magnitude of the shock, and if pur-
chased, insurance will recover any health lost to the shock.
Listed below is the event timeline faced by players in our model. Each period, t, is subdivided
into the following four stages:
1. Investments ~It =
{
IHt , I
J
t , I
R
t , I
I
t
}
are set.
2. Intermediate health Ht′ is determined for the current period considering health at the end of
last period, health improvement R(Ht, IHt ), health degradation δ, and whether the stochastic
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health shock ∆t(IRt ) is realized.
3. Joy Jt(IJt , Ht′) and income M(Ht′) are computed based on investments and intermediate
health.
4. ∆t(IRt ) health is recovered if insurance was purchased and a health shock occurred, yielding
a final health Ht+1.
Figure 1 shows the events each period and when health is a level Ht versus Ht′ . We included
the health experienced Ht′ so that players incurred a penalty from a shock even if insurance was
purchased, capturing the real-life costs of health shocks outside of medical bills. Additionally,
placing insurance recovery at the end of the period is equivalent to a cash payout that is earmarked
towards next period’s health, IHt+1. This allows for direct comparisons between insurance purchase
and self-insurance through savings.1
Healtht Healtht′ Healtht+1
1
Investment decisions
2
Investment improvement
Fixed degradation
Shock realization
3
Income earned
Joy received
4
Insurance improvent
Figure 1: Sequence of Events within a Period
The equations that govern the individual’s welfare maximization problem are:
Maximize:∑
t=1,T
J(IJt , Ht′) (Lifetime Joy)
Subject to:
Ht′ = Ht − δ +R(Ht, IHt )− xt∆(IRt ) (Health Experienced)
Ht+1 = Ht′ +D
I
t xt∆(I
R
t ) (Health at start of next period)
St +
∑
k
Ikt = St−1 +M(H(t−1)′) (Budget constraint)
Where:
1An additional constraint is that the health improvement function must be additive with investments so that if I is
the cash equivalent insurance payout, then R(Ht′ , I) +R(Ht+1, IHt+1) = R(Ht′ , I + I
H
t+1)
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J(IJt , Ht′) is the joy realized in period t.
xt is the realization of the shock degradation random variable Xt ∼ Ber(µt), where µt is
a fixed probability of a shock depending only on age.
IIt = D
I
t ρt(I
R
t , Ht′), with D
I
t ∈ {0, 1} being the binary decision whether to purchase
insurance, and ρt(IRt , Ht′) being the insurance premium that may depend on health,
shock size and shock probability.
2.2.1 Optimization
Health investment IHt increases future income and joy potential. Joy investment I
J
t increases utility
in the current period. Resilience investment IRt reduces any health loss from a shock this period,
resulting in higher expected income and joy, as well as the potential of a lower insurance premium
depending on how the premium is calculated. Purchasing insurance DIt pays for the significant
cost of health recovery should a shock occur, both freeing up future budget and reducing health
uncertainty. Balancing these investments across time comprises a difficult dynamic optimization
problem.
From the first order conditions of the optimization, we find that: 1) investments in health will
decrease as the number of remaining periods decrease; 2) investment in resilience will increase
as risk of shock, µ increases; 3) optimal saving will increase if µ is higher in future periods, and
decreases as the number of future periods decreases; 4) purchase of insurance will increase as risk
of shock, µ, increases or as price, ρ, decreases.
Additionally, the investment in resilience and insurance purchase are heavily dependent on one
another.2 Purchasing insurance negates the benefits of resilience in future periods since any shock
is recovered from. Meanwhile, investing in resilience reduces the value of the insurance. However,
they can also act as complements. When insurance premiums are calculated to be actuarially fair,
conditional on purchasing insurance, the marginal cost of resilience is reduced as it also results in
lower insurance premiums.
In the Results Section, we analyze data generated by a computerized dynamic program (DP)
that maximized total expected joy received in a life. The DP calculated maximum expected joy for
2While health level influences insurance price and hence health investment does as well, in practice, the effect is
minor within a period.
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each possible combination of the two state variables (health and savings) for every period and every
shock sequence. Then, working from the last period back, the DP found the optimal decision path
given any possible shock sequence experienced by a subject. Results will detail how the optimality
conditions discussed above map into an optimal decision path given the parameters we describe
below.
2.2.2 Functional Forms and Parameters
This subsection presents the specific functional forms we employed in the experiment, in order to
implement the general theoretical model discussed in the above two subsections. We begin with
the functional forms of the joy, health regeneration, resilience and income functions.
Jt(I
J
t , Ht′) =
IJt
(γ + IJt )
Ht′ (1)
R(IHt , Ht) =
eαI
H
t
eαI
H
t + (1−Ht)/Ht
−Ht (2)
∆(IRt ) = Φe
−rIRt (3)
M(Ht′) = Ht′Ω
c (4)
The joy function, Equation 1, has diminishing marginal returns to consumption, IJ and moder-
ated joy realized by health experienced. The consumption term is asymptotic so that like the health
term it has an upper bound. The health regeneration function, Equation 2, is logistic. Improving
health is least expensive at the middle of it’s range, and progressively more expensive toward ei-
ther end of the range. It is more expensive when health was high to model diminishing marginal
returns, and more expensive when health was low to model the complication of treating co-morbid
health issues. The specification also ensures that increasing health had the same cost no matter
how many periods the subject to make the increase over. The shock moderation function, Equation
3, imposed diminishing returns to investments in resilience, IR, the ability to moderate shocks. The
income function, Equation 4, was linear and increasing in health experienced. Additionally, income
depended on income type, (SEC).
In the experimental environment that is used to implement this model, health is restricted
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to values from 100 (perfect health) to 0 (death). Life starts with health at 70 (H0 = 70) and
depreciates by 8 (δ = 8) each period with certainty. In addition, health declines further if there
is a shock in a given period. The shock probability is 3/12 in the first half of life (µt = .25 for
t ≤ 16), and 5/12 in the second half (µt = .4167 for t > 16). The unmitigated shock was set to
25 health points (Φ = 25), but could be reduced to as low as 12 through the purchase of resilience
IR. We use Equation 3, but impose a maximum investment per period and limit it to take on
integer values. The shocks are pseudo-random. We use pre-generated sequences that rule out low
probability sequences and reduce variation.
To explore the heterogeneous impacts of insurance plans we create two types of variation in
the population. A Subject is either high or low income. Actual income for both types is health
multiplied by their type constant. The constant Ωc for the high-income type was 200, 1.25 times
greater than the one for the low-income type, 160. While we refer to the types as high and low,
both types had sufficient income to income to purchase insurance so might be better described as
high and middle income. For all levels of health below 35, the subjects received the minimum
income, the same amount as if they had a health of 35. For both income types we increase the
probability of health shocks during the second half of life when the subjects become old, creating
an addition level of variation.
Under the ‘employer’ insurance plan, the employer paid 75% of the insurance premium cost,
which subsidy was fully funded through wage reductions that were universally imposed on all
employees, regardless of whether the individual chose to purchase the insurance. All employees
were offered the opportunity to purchase insurance at a fixed cost that was approximately 25%
of the real cost of insuring the average person in the pool. The constant deduction rate across
incomes (18%) meant that the system transferred contributions from high to low income, while the
constant premium cost regardless of age transferred contributions from young to old. Calculations
of exact amounts are in Table A.3. Our environment is mathematically equivalent to an overlapping
generations’ model3.
3The employer age transfers did not require any delay, and could have transferred from young to old within a period
had, there been subjects of both types within periods. However, we avoided the logistical complications required to have
subjects of varying ages.
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Figure 2: Subject Interface
2.3 Experimental interface
Figure 2 shows the experimental interface seen and manipulated by the subjects. The heart icon
represents health. The happy face denotes joy. Each shows the present value, and the resulting
values next period with and without a shock. Income is in the top left and is the first number
under the money icon. Money can be allocated to health or joy by moving the respective sliders
below the graphs in the top center. The graphs allow the subject to see the diminishing marginal
returns of both. Subjects make insurance and resilience decisions by checking boxes below the
graphs. Remaining budget and potential outcomes update dynamically with each decision. Any
unallocated money is saved, and added to income next period. Saving is possible for any number
of periods but not across lives. Savings held at the end of life were lost. Subjects were paid based
on the sum their received joy across all periods and lives.
In the shock stage, the wheel in the upper left corner spins. If the pointer lands on the section
with the storm cloud icon, the subject receives a shock. The shock section of the wheel is pro-
portionately larger during the second stage of life to convey the increased probability of a shock.
Subjects could see what health and joy would be with a shock on the middle line in the upper left
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corner; the lower lines in the graphs represent values when shocked. The outcome stage is when
the subjects receive joy and income. It was a separate stage to make it clear that both were based
on the subjects’ health, including reductions from any shock received that period. In the final stage,
if the subject had bought insurance that period, health was restored to its pre-shock level. If the
subject was uninsured or self-insuring through savings, they could pay to restore their health in
the first stage of the next period. Income and savings in the experiment had no direct impact on
subject payments.
Subjects are organized into groups of four individuals with the same income type. The right side
of the screen shows the group history for the present life. There are graphs for health, cumulative
joy, and budget. Each graph has a colored line for each group member that corresponded with the
member’s tile color and label. The bottom right corner displays each member’s fitness history in a
heatmap style graph, with dots indicating insurance purchase decisions. The numbers in the shield
indicate resilience levels. The umbrellas indicate being insured. These icons correspond to ones
used in spending decisions.
Subjects could choose whether to chat with other group members through text. The bottom cen-
ter is the chat section. Chat is available at all times including in pauses between lives. Even though
subjects can chat, subject payouts from the experiment depend solely on individual performance.
There is no financial reward to sharing information, nor is there any incentivized competition giving
reason to withhold information.
After thorough on screen and audio instructions, subjects participate in three practice lives of 4,
16 and 16 periods, before engaging in the two longer 32 period lives that we analyze. All periods
for all lives are paid. A subject who dies (i.e. Health = 0) in a particular life must wait until all
the other subjects in the experimental session complete that life, but can chat with other group
members and observe all their actions.
2.4 Procedures
We ran 12 experimental sessions at the Economic Science Institute (ESI) Lab at Chapman University
between April 24th and May 16th, 2018. Eight sessions had 24 subjects, two had 20, one had 16
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and one had 12.4 Subjects were recruited via email from a database of subject volunteers ESI
maintains. Table 1 shows the 2x2 treatment design and number of subjects in each cell. Sessions
lasted 120 minutes. Average subject earnings were $36.79, including the $7 show-up fee.
Table 1: Subjects per treatment cell
Treatment
Actuarial Employer
Low-Income 64 68
High-Income 64 64
Table 2 lists insurer details by treatment. The premium in the Actuarial treatment was the
expected cost plus 10% (to model administrative costs). Cost was always $9 in the Employer
treatment. Subjects in the Employer treatment received only 82% of the income they would have
received in the Actuarial treatment. (The ‘employer’ decreased wages by 18% to fund the insurance
subsidy.) Withheld income is the mean of the total difference in income across subjects’ lifetimes.
Insurer revenue is defined as the sum of all premiums paid (in both treatments) plus all income
reductions to subjects (in the employer treatment). Profit is defined as revenue minus the total
amount paid to the subjects to recover from insured shocks. The profit rate is the profit divided
by the revenue. The actuarial treatment had a slightly lower profit rate (7.3%) than designed,
because, by chance, the stochastic shock rate on the periods when subjects did not buy insurance
was lower than the rate during periods when insurance was purchased. The insurer profit rate in the
employer treatment (5.2%) was lower than in the actuarial treatment, however, the revenue stream
was larger due to much increased subscription, so overall the insurer made more profit under the
employer plan ($48) than the actuarial plan ($36). The table demonstrates that the subsidies under
the employer plan were completely funded, and no ‘external’ resources were required.
2.5 Data Analysis
Our regressions on insurance purchase and survival will use a panel data probit model:
Yit = Π(φi + τi + νi + εit)
4When there were fewer than 24 subjects, the number of subjects was a multiple of four so that all subjects had
equal-sized groups. The subjects, who remained after the maximum number of groups of four was formed, were paid a
show-up fee and allowed to depart.
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Table 2: Treatment Details
Actuarial Employer
Premium 1.1 * E(Costit) $9
Subject Income 100% 82%
Withheld Income 0 654
Premiums Collected 442 259
Total Revenue 442 913
Benefits Paid 409 865
Insurer Profit $32 $48
Profit Rate 7.3% 5.2%
where φi is a vector of sub-population binary variables indicating the subject’s age within the
experiment life {young, old} and income type {low, high}; τi is vector of binary variables indicating
belonging to a particular sub-population and being in the employer-based insurance treatment; νi
is an individual error term; and εit is period and subject specific error term. Errors are clustered
according to which shock sequences (there were only twelve) the subjects experienced.
Our regressions on resilience, health, savings and joy will use a panel data model:
Yit = φi + τi + νi + εit
where the variables have the same specifications, but there is no link function.
3 Results
3.1 Theoretical results from dynamic program
Figure 3 shows optimal results from dynamic program for the four treatment groups, based on the
12 shock patterns to which experimental subjects were exposed. Red and orange plot the welfare
maximizing strategy (i.e. maximizing expected lifetime joy) in the employer treatment for high
and low income, respectively, and blue and green do so for the actuarial for high and low income,
respectively.
Insurance Purchase – Panel 3a plots the proportion of simulated subjects purchasing insurance
in each period. Consistent with theory, purchase rates are higher in the employer treatment. The
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Figure 3: Results from Dynamic Program
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DP predicts insurance purchase for all subjects in the employer treatment, regardless of income,
whereas in the actuarial treatment, the proportion purchasing insurance is about 50%, generally
decreasing across life. In the actuarial treatment, a greater proportion purchase insurance in the
low than the high-income treatment. Generally, the DP tended to self insure so did not purchase
unless it encountered shock realizations which depleted the savings required for self insurance.
Resilience - Panel 3b plots mean resilience level to shocks. In the employer treatment, there
is the moral hazard predicted. Both income types make no resilience purchase until starting the
endgame whereas in the actuarial treatment, both high and low-income subjects invest in resilience.
In the actuarial treatment, consistent with theory, investments in resilience increase when shock
probabilities increase in the second half of life, but to a lesser extent among the lower income
subjects.
Health - Panel 3c shows that the DP predicts relatively small differences in health levels between
treatment groups. Health levels are smoothed across life except for a sharp decrease in the end of
life. It also takes a couple periods in the beginning of life to achieve optimal levels. This is an
artifact of the chosen starting health level; had we chosen a higher starting level, there would be
no build up period.
Survival - Panel 3d shows that given the model parameters used, it is not optimal to die before
period 32 in any of the four treatments.
Savings - For all treatment groups, Panel 3e reveals that the DP predicts savings will increase
through the first half of life and then decrease in the second half of life. Transferring money from
early period to later period allows for the smoothing of consumption and health levels. Optimally,
savings will be about four times as high in the actuarial than in the employer treatments. The
relative benefit from employer insurance to the income withheld is negative when ‘young’ and
positive when ‘old’, so the treatment transfers funds without active ‘savings’ required. The effects
of income on savings are much smaller in comparison.
Joy - DP predictions in Panel 3f indicate that more joy is obtained in the actuarial than in the
employer treatment. However, there is an interaction between insurance treatment and income
with larger differences between insurance treatments among the higher income groups. The DP
largely smooths joy across life. Joy investments are low in the beginning of life when the priority is
increasing health and therefore income. Conversely, at the end life joy is increased.
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Together, the theoretical results reveal that optimal strategies depend on both insurance plan
and income, and change dynamically through life. The decreased premium costs in the employer
treatment through the subsidy result in the universal purchase of insurance and reduced savings,
and resilience. Reduced investments in resilience reflect moral hazard in that at the individual level,
premiums do not change with respect to expected insurer costs. The actuarial plan with greater
individual responsibility requires a complex dynamic mix of savings, resilience and investments in
health. However, since it is unconstrained by an imposed employer subsidy, it results in greater total
welfare, especially for the high income group. Interestingly, the DP also predicts greater insurance
purchase in the actuarial low income treatment, as there is less ability to buffer shocks through
savings or investments in resilience.
3.2 Subject results
Figure 4 presents temporal plots of mean subject data akin to the plots of DP data in Figure 3. (Table
A.1 of the Appendix provides the summary statistics for the subject data plotted.) The degree of
correspondence between the DP and subject path varies according to insurance type, income level
and variable. We provide detailed analysis organized by variable below. Table 3 reports regression
results that provide statistical tests of the differences between the results represented in the graphs.
The six table columns labels (a-f) correspond respectively to the six panels in the graphs. For all
columns, estimates are reported for seven binary indicator variables. The first three variables
represent the four sub-populations resulting from interacting age and income (low-income young
is the omitted sub-population), so each variable provides an estimated impact of belonging to that
sub-population relative to the omitted one. The remaining four variables indicate both belonging
to a particular sub-population and being in the employer-insurance treatment, so they estimate
specific effect (of insurance type) for each of the four sub-populations.
Insurance Purchase – Qualitatively, the paths of subject decisions match those of the DP, includ-
ing the endgame effect. In contrast to the actuarial treatment, nearly all subjects of both income
groups in the employer treatment purchased insurance every period except the last, as predicted by
the DP. The greatest difference between the DP predictions and subject behavior is in the actuarial
treatment. Actuarial subjects purchased less insurance than is optimal in the first quarter of life
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Figure 4: Results from Subjects
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and more than is optimal in the second and third quarters of life. Low-income subjects purchased
insurance at greater rates than high-income subjects.
Column (a) of Table 3 presents estimated marginal effects of a probit regression on insurance
purchase. In the actuarial treatment, the low-income, young subjects purchase insurance at the
highest rates, because they are most vulnerable, having the least savings and future disposable
income with all future periods at stake. The difference between the purchase rate and each of the
other three sub-populations is statistically significant, as is reported in the first three rows. The
sizes of the estimates are consistent with their relative vulnerability. Subjects in all sub-populations
are statistically significantly more likely to purchase insurance in the employer treatment.
Resilience – As predicted by the DP and theory, subjects invest more in resilience in the actuarial
than in the employer treatment (the moral hazard effect), and investments in resilience increase
in the second half of life when the shock rate increases (Panel b). Again, however, subjects in the
actuarial treatment diverge more from the predictions of the DP by under-investing. Whereas the
DP predicts an increase to a resilience level of almost four for both low and high income subjects,
their observed resilience levels are less than 1 for the first half of life and only increase to a mean
of about 1.25 in the second half of life. Column (b) of Table 3 reports coefficient estimates from
a linear regression on resilience (ordered probit results are in the Appendices). Subjects maintain
higher resilience during the second (old) half of life, as can be seen in Row 1 and 3. Consistent
with moral hazard, the difference across insurance treatments is statistically significant for all four
sub-populations, and the difference is larger in the second half of life.
Health – Like the DP, subjects maintained relatively high levels of health throughout life (Panel
c). However, subjects in all treatments under-invest in health in the early periods of life, resulting
in lowered income throughout life because of less joy realized during later periods of life. Again,
subjects in the actuarial treatment, especially low-income subjects, differ more from the DP than
those in the employer treatment.
Column (c) of Table 3 reports coefficient estimates from a linear regression on health. Health is
over 13 points lower for low-income old subjects. The employer treatment largely diminishes this
effect, so the difference is only a third of that in the actuarial treatment.
Survival – 91% all of subjects survived through both lifetimes, close to the DP, which had per-
fect survival employing optimal decision making regardless of shock sequence experienced. Some
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Table 3: Regression estimates for baseline differences and treatment effects
(a) (b) (c) (d) (e) (f)
VARIABLES Ins. Purchase Resilience Health Survival Savings Joy
Low Income Old -0.0760*** 0.532*** -13.14*** -1.542 -22.10***
(0.0201) (0.0886) (1.669) (3.169) (2.788)
High Income Young -0.150*** 0.0991 3.132* 5.692** 25.93***
(0.0364) (0.0950) (1.656) (2.649) (2.006)
High Income Old -0.0852*** 0.676*** -4.008 0.117** 1.373 10.15**
(0.0262) (0.0966) (2.591) (0.0527) (2.881) (4.136)
Emp * Low Young 0.372*** -0.692*** 2.410 -5.645 -3.016
(0.0362) (0.0496) (1.797) (3.739) (2.303)
Emp * Low Old 0.408*** -1.144*** 8.401*** 0.127*** -7.906*** 11.62***
(0.0340) (0.0716) (2.579) (0.0244) (2.897) (2.743)
Emp * High Young 0.414*** -0.711*** -2.103* -15.61*** -8.239***
(0.0293) (0.0863) (1.267) (1.925) (2.336)
Emp * High Old 0.352*** -1.124*** -0.481 0.0224 -10.81*** 0.252
(0.0258) (0.0847) (2.138) (0.0686) (1.619) (3.803)
Observations 16,640 16,640 16,640 455 16,640 16,640
Sequence Controls Yes Yes Yes Yes Yes Yes
Log Likelihood -6139 -127.9
Rho 0.513 0.467 0.461 0.0949 0.612 0.220
P-value < .001 < .001 < .001 < .001
Number of Subj. Lives 520 520 520 520
Clustered (on Shock Sequence) standard errors in parentheses *** p<0.01, ** p<0.05, * p<0.1
subjects died due to under-investments in health and resilience, especially in the low-income actu-
arial treatment in which 20% died.
Column (d) of Table 3 reports probit estimates on whether the subject was alive at the end
of the 32 period life, so there are no estimates for young subjects. Sixty-five subject lives were
dropped from the regression because their innocuous shock sequences perfectly predicted survival.
Under the actuarial treatment, being high-income increased a subject’s chance of survival by 11.7%.
Employer insurance closes the income survival gap as fewer low-income subjects die prematurely.
There is no reason that low-income subjects should be more likely to survive, and the difference is
not significant.
Savings - As predicted by the DP, subjects in the actuarial treatment save more than those
in the employer treatment, and high-income subjects save more than low-income subjects (Panel
e). However, compared to the DP, subjects in all treatment groups under-invested in savings, and
none of the treatment groups supported the DP prediction of a dramatic increase in savings during
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the first half of life followed by a decrease in savings during the second half of life. Again, the
divergence between DP predictions and subject behavior was greatest for the actuarial treatment:
only 20 out of 256 subjects in the actuarial plan had savings of 75 or more (near optimal) at midlife
(period 16).
Column (e) of Table 3 shows regression estimates of how savings differed by sub-population.
Only the high-income young had a statistically significant difference in savings. The employer
treatment reduced savings for all four sub-populations, but the reduction for low-income young
subjects was not statistically significant. The relatively small savings estimates highlight the fact
that the subjects did not optimize savings in any of the treatments. The largest sub-population
mean savings estimate is only 16, whereas optimal behavior would have produced a regression
estimate of about 80 (half the peak savings).
Joy – Subjects in all four treatment groups experience less joy than achieved by the DP This
is due mostly to the under-investments in health, savings and resilience early in life. The results
also reveal an interaction between the income and insurance treatments. As predicted by the DP,
joy is higher in the actuarial than in the employer treatment for higher income subjects, especially
during the first half of life. However, in contrast to the DP, low-income subjects realized less joy in
the actuarial than in the employer treatment, particularly during the second half of life.
Column (f) reports estimated difference in joy earned within period. Young earn more than
old and high-income earns more than poor. The only two of the estimates for insurance effects are
statistically significant.
3.3 Treatment effects on lifetime utility
As these the cumulative impact not clear from period estimates, Table A.2 provides estimated cu-
mulative effects of the insurance and income treatments over the 32 period life. In regressions (see
section A.2), impact of employer insurance was 128 for high-income subject, 138 for low-income
subjects, and -5 overall. It is only statistically significant for low-income subjects. These results
underscore the transfers of welfare that occurred in our test environment (see section A.3 of the
Appendix for a detailed economic breakdown of the transfer and moral hazard effects).
Table 4 compares mean joy earned in the Actuarial and Employer Treatments by DP maximiz-
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ers and human subjects. The results confirm significant interaction between income and insurance
treatment in obtaining joy. As predicted by the DP, high-income subjects obtained more joy in the
actuarial than in the employer treatment. But contrary to the DP prediction, low-income subjects
did absolutely better in the employer than in the actuarial treatment. As such, differences in ob-
tained joy between low and high-income subjects were significantly greater in the actuarial than
in the employer treatment, with low-income subjects obtaining 73% of the joy high-income sub-
jects obtained in the employer treatment, but only 64% in the actuarial treatment. Similarly, if we
compare subjects performance relative to optimal, low-income actuarial is the clear outlier, at only
69%, whereas the three groups are at 75%± 1%.
Table 4: Obtained Mean Joy
Low Income High Income Low/High
Subj DP Subj/DP Subj DP Subj/DP Subj DP
Employer 1816 2391 0.76 2482 3213 0.77 0.73 0.74
Actuarial 1679 2423 0.69 2609 3462 0.75 0.64 0.7
Emp/Act 1.08 0.99 0.95 0.93
Figure 5 illustrates how subject behavior results in utility losses relative to optimal play, and
how those losses accrue across life. Results for high- and low-income subjects are presented in
Panels 5a and 5b, respectively. Within panels, the blue bars plot actuarial values and the red bars
plot employer values. For each subject in each period, we calculate the best and worst decisions
that subjects could make for maximizing joy over the remainder of their life, taking into account
current health and savings. Given the joy actually earned in previous periods, the top of each
period-bar (‘optimal play’) is the mean across all subjects of total lifetime joy that each subject
could obtain by making the best possible decision in that period and then playing optimally for the
remainder of life. The bottom of each bar represents ‘pessimal play’ for that period. It is the mean
outcome associated with the worst possible decision in that period, but then playing optimally for
the remaining periods of life. The bold line within each bar is the mean of observed actual play.
The distance from the top of the bar to the subject mean line shows the mean amount of joy lost
for that period, compared to optimal play. The sum of all those losses is equal to the distance from
the top of the bar in period 1 to the observed bold line in period 32, and can be thought of the
total lost joy associated with making the observed rather than optimal decisions. The distance from
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Figure 5: Joy earned by subjects compared to optimal
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the subject play to the pessimal line shows how much more joy subjects could have lost by making
worse decisions; and the total length of the line shows the spread between the worst and best
decision. Finally, the dotted lines in the red employer bands show the mean expected aggregate
joys with a pessimal decision, but are conditional on subjects always buying insurance.
Three conclusions are evident from Figure 5:
1. The length of the vertical bars is greater for the actuarial treatment than for the employer
treatment for both income levels, indicating a greater potential for costly errors in decision
making. This difference becomes even more extreme if the employer bars are limited to
the dotted (buy insurance) regions – a decision nearly all subjects made in the employer
treatment.
2. As life progresses potential aggregate joy in the actuarial treatment decreases more than in
the employer treatment. This impact is much larger for low-income subjects for whom the
actuarial bars starts above the employer bars but quickly fall and stay below, revealing the
greater cost of non-optimal decisions under constrained income.
3. In any given period mean subject performance is generally much closer to the optimal than
the pessimal decision, but across life these slightly non-optimal decisions accumulate to con-
siderable losses in aggregate joy.
4 Discussion
Our first major finding is that the employer treatment reduced utility differences between high- and
low- income subjects and between the first (low-shock-risk) and second (high-shock-risk) phases of
subjects lives. These reductions in disparities were due to transfers and risk sharing. The fact that
insurance premiums did not change as subjects ‘aged’ in the employer treatment resulted in de
facto transfers from young to old which, in turn, resulted in greater smoothing of joy realized
throughout life. Transfers from higher to lower income subjects in the employer treatment also had
a direct impact on respective joy earned, reducing the difference between high- and low-income
subjects. Of particular significance, is that the individual responsibility in the actuarial treatment
was particularly detrimental to the lower income subjects. Even though their income was only 25%
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lower, a much greater proportion of the low-income subjects died before the end of the 32 period
life and the total joy they obtained was 36% lower than high-income subjects.
Risk sharing in the employer plan meant that insurance was always affordable even to subjects
who had high expected cost and low income due to poor choices. Thus, subjects in the employer
plan were able to protect themselves from shock and survive, whereas in the actuarial plan below
a particular health (income) level recovery and survival is impossible. These results are consis-
tent with the expectations that the incentives entailed by individual responsibility reduce health
care costs through increased investment in prevention, but are associated with increased health
disparities both between old and young and between rich and poor.
A second finding is that endogenous investments in health interact with the institutional and eco-
nomic environment in ways suggested by the DP’s welfare maximizing agents. The experimental treat-
ments manipulating how health insurance premiums are determined and subject income affected
their decisions about how much to invest in health and whether to buy insurance. While there are
several laboratory experiments in which individuals must make dynamic decisions in multi-period
lives (Ballinger et al., 2003, Gillet et al., 2009, Carbone and Infante, 2014, 2015), our environ-
ment presented the additional complications of random shocks and multi-variate allocations. Yet,
subjects are still able to engage in arbitrage between present and future utility gains, and they are
able to buffer against risk through savings, resilience and the purchase of insurance. Below is a
summary of the predictions from the DP, to which subject behavior conformed qualitatively (see
Tables A.5 and A.6 for a complete summary of our results):
1. Subjects invested in health, insurance, and resilience in ways that kept 91% of them alive
throughout their 32 period lifetimes, with sufficient patience and forethought to smooth con-
sumption throughout life.
2. Subjects discontinued investment in health as the endgame approached.
3. Subjects in the employer treatment purchased more insurance but invested less in resilience
than in the actuarial treatment, resulting in greater total insurance payouts.
4. Low-income subjects purchased more insurance than high-income subjects, particularly in the
actuarial treatment.
5. High-income subjects earned more in the actuarial than in the employer treatment.
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However, there were some important deviations from the welfare maximizing investment pat-
terns suggested by the DP:
1. Subjects under-invested in health at the beginning of life and over-invested in health at the
end of life in all treatments.
2. Subjects under-invested in resilience throughout life in the actuarial treatment, undervaluing
the marginal effects of resilience in reducing the size of a health shock.
3. Subjects in the actuarial treatment deviated from the predictions of the DP more than subjects
in the employer treatment, especially with respect to savings and resilience.
4. Low-income subjects in the actuarial treatment had less cumulative joy than in the employer
treatment, even though the DP predicted they would earn more joy.
Although the actuarial environment has higher potential maximum joy, because choices are not
constrained by an obligatory employer tax to subsidize health insurance premiums, subjects in the
actuarial environment performed relatively worse, compared to their DP optimum, than those in
the employer environment. The greater deviation between the predicted and observed behavior in
the actuarial treatment suggests that the increased complexity of the decision environment in the
actuarial treatment reduces subjects’ abilities to optimize their choices dynamically. Our results are
consistent with a related literature, originating with Iyengar and Lepper (2000) and summarized
by Chernev et al. (2015), showing the number of choices negatively impacts on quality of choice.
Our findings are also consistent with research finding poor comprehension of health insurance a
strong preference for simpler plans (Loewenstein et al., 2013). Theoretical gains from plans that
eliminate moral hazard assume sophisticating in long term planning that most people are incapable
of so such gains are unlikely to be realized. This is despite that stated-effort levels for fitness are
likely to exceed real effort levels, and give the actuarial plan a “best shot‘’ at outperforming the
employer plan which is subject to moral hazard. Fitness that requires distastefully exercise or
restriction of pleasurable consumption is likely to be lower. Fitness is already near zero in the
employer plan so reduction will be greater in the actuarial plan decreasing subjects’ outcomes in
that plan.
Several findings raise questions that should be addressed in future research. One question
concerns the interpretation of moral hazard. While subjects invested more in resilience in the
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actuarial than the employer treatment, as predicted by moral hazard, they still invested much less
than DP predicted. This finding suggests that providing premium discounts for subjects to engage
in healthier behavior that lowers the expected cost of health shocks would have some effect on
their behavior, but it would be a smaller effect than would be predicted by DP maximizer behavior.
Individual responsibility in a complex decision environment with unpredictable shocks may result
in underinvestment in the future, and not generate the expected efficiency gains, associated with
incentives to invest in health. Admittedly, the subjects in our experiment were not informed about
how insurance was priced—they were told they would have the option buy insurance and the
price would shown on the screen. The intention was avoid any experimenter demand effects. A
byproduct is a reduced saliency of the role of fitness in insurance price. However, despite not being
told, the interface dynamically updated the price of insurance when the subject changed fitness
level. However, given that less than 3% of Americans follow four major guidelines for healthy
behavior Loprinzi et al. (2016), our findings are consistent with empirical patterns observed in
the real world. This raises the question of why direct economic incentives produce smaller than
expected effects on health maintenance. More importantly, it also raises the question of what other
incentives might produce larger effects.
Another issue provoked by our results concerns whether a hybrid insurance system, combining
elements of the actuarial and employer systems might produce the greatest social welfare. The
employer-based system aims to increase social welfare by decreasing the complexity of the decision
space and by seamlessly implementing the transfer from the young to the old and from higher
to lower income individuals. The actuarial system incentivizes health investments, and therefore
aims to increase social welfare by decreasing average premium costs and the actual burden from
repairing health shocks. Might an Employer-based system with premium incentives for health
behavior outperform the two systems we investigate here?
A final question concerns health insurance purchase. Subjects in the low-income actuarial treat-
ment purchase more insurance than those with higher income, as predicted by the DP. This appar-
ently reflects a greater gain from buffering risk as income decreases in our environment. The
experimental result seems somewhat contrary to observational data findings in which low-income
individuals are less likely to be insured (Berchick et al., 2018). We first note that subject decisions
qualitatively match DP decision; subjects in the low-income treatment insured at higher rates, but
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had lower resilience relative to high-income subjects, so were correctly allocating given the varia-
tion in marginal benefits. We do not know, however, if an even lower income treatment would have
reversed this effect. One potential implication of our results is that low income individuals in the
world outside the laboratory are more risk sensitive than higher-income individuals. It may be that
impediments to the purchase of health insurance, such as financial constraints, income interrup-
tion, under-forecasted expenditures, and difficulties interacting with governmental agencies, may
better explain SES effects on health insurance coverage than insensitivity to risk. Such effects may
force lower income people to insure through informal mechanisms, even at considerable expense,
to prevent the extremely harsh consequences a negative shock would cause them (Banerjee and
Duflo, 2007). This issue deserves further experimental investigation.
The limitations of our study should be considered in interpreting these results. First, vir-
tual ‘health’ in an experimental environment may be experienced very differently than real-world
health. Behaviors, such as diet, exercise, and tobacco, alcohol and drug use, may be experienced
and motivated differently than moving levers to pay for improved health in an economics labora-
tory. What is very encouraging, however, is that our subject behavior matched most of the quali-
tative predictions of the DP welfare maximizers, and deviations from maximizer behavior, such as
under-investment in health and resilience, are commonly observed in the real world. Neverthe-
less, assessments of the experimental environment’s validity with respect to actual health behavior
are necessary for evaluating the productivity of the approach. Two future experiments we plan
to implement to test validity are: 1) perform multi-day experiments that substitute real-effort,
accelerometer-measured exercise for investments in resilience while maintaining other features of
the experimental protocol; and 2) conducting the experiments with other ethnic and SES groups
as opposed to university students to evaluate the generality of the findings.
While it was employed to enhance treatment effects, a design limitation might be that all sub-
jects were endowed an initial health stock of 70/100 at the beginning of the experiment. Many
subjects tended to maintain this stock with small deviations (±5) from period to period until the
endgame in which they allowed it to deteriorate. It is unclear whether they would have main-
tained a higher, ‘near optimal’ level of 75-80 if that were their initial allocation, or whether and
how quickly they would have allowed their health to deteriorate if their initial stack was higher
than optimal. However, the experiment had three training lives and chat groups with complete
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public information on like-subjects’ behavioral choices. This allowed the subjects to jointly explore
their strategy space, prior to the 32 period lifetimes. This suggests that the behavioral proclivities
observed are not the results of anchoring effects.
Finally, the disposable income differences between the treatment groups were relatively small
(80⇔ 100), compared to potential income differences in the real world. It is possible that the effects
we found are limited to small differences in income and that expanding the difference might lead
to non-monotonic relationships.
5 Conclusion
These results have theoretical, policy and methodological implications. Even though in theory and
under optimal play the actuarial plan had higher potential life satisfaction, we find that it did not
outperform the employer plan in our experiments. The gains in efficiency due to individual respon-
sibility in the actuarial were modest, because subjects under-invested in savings and resilience to
shocks, compared to optimal play. The low fitness observed in the actuarial treatment suggests con-
cerns about moral hazard are overemphasized in policy debates. On the other hand, the employer
plan resulted in a simpler decision space and significantly reduced disparities between income lev-
els and phases of life. Thus, in this application, the advantages of risk-sharing and transfers appear
to outweigh the gains from incentives for individual responsibility.
The findings from this experiment illustrate the benefits of the experimental laboratory, as a
complement to existing research methods. This method allows us to simulate a complex, multi-
variate dynamic health decision environment and assess lifetime effects. At the same time, it per-
mits controlled experimental manipulations of policy alternatives whose evaluation is not impeded
by selection biases. A major challenge that confronts this experimental approach is whether it can
be applied with validity to real-world health behavior. Validity assessment is a clear next step, but
the results obtained so far are encouraging.
There is ample scope for mutual translation from such experiments to observational research
and real policy manipulations. Hypotheses generated from population-based studies could be tested
with controlled laboratory experiments, and findings from laboratory studies can motivate new
analyses of population data. Such experiments can be used to explore whether policies that under
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consideration will result in expect effects and have untoward and unexpected consequences. Simi-
larly, the results of existing policy experiments, such as Romneycare and the ACA, can inform new
experimental treatments to isolate causality and to assess modified policy alternatives.
More broadly, the experimental environment can be adapted to address other issues in which ob-
servational studies were unable to reach conclusive findings due to insufficient data or co-linearity
of important variables. There is the potential to disentangle, for example, the relationship between
education and health, as well as conduct experiments addressing chronic disease and how social
norms and learning impact health decisions. These factors potential interact with insurance policy.
We advocate that environment like ours are a low-cost alternative to understanding these nuance
of health behaviors before proceeding to field studies and wholesale policy changes.
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A Appendices
A.1 Summary statistics
Table A.1 presents the descriptive statistics regarding subject decisions and outcomes for the four
experimental treatments in the first and second halves of life.
Table A.1: Summary Statistics
Low Income High Income
Actuarial Employer Actuarial Employer
Young Old Young Old Young Old Young Old
Insurance Purchase 0.61 0.60a 0.94 0.98a 0.40 0.51a 0.88 0.94a
Resilience 0.78 1.48 0.07 0.15 0.86 1.48 0.15 0.33
Health 63.91 56.16 64.42 57.61 65.36 60.05 63.79 60.13
Savings 15.92 12.46 9.91 6.11 21.04 16.29 5.51 5.00
Joy 79.75 82.16 79.75 82.16 79.75 82.16 79.75 82.16
Income 102.31 94.79 83.33 78.09 129.52 124.64 103.33 100.63
Average Lifetime 29.4 31.9 31.4 31.1
Premature Deaths 26 5 9 7
a Excluding last period.
A.2 Cumulative joy
Table A.2: Coefficient estimates from regressing cumulative Joy on insurance type
(1) (2) (3)
VARIABLES Low Income High Income All
Employer 137.7* -127.8 -5.127
(72.75) (90.03) (76.43)
Observations 264 256 520
# of Subjects 132 128 260
Robust standard errors in parentheses
*** p<0.01, ** p<0.05, * p<0.1
A.3 Transfers
Table A.3 provides calculations of the transfers in the employer based insurance. Profit (pi) per
period for each group of subjects is the Insurer’s “Payout” less Withheld (from subjects’ income)
and Premium paid. Sum-zero subtract one quarter of $6.43 of insurer profit from each group. This
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column sums to zero and is the inter-group transfers. Mean transfers from young to old are $7.65,
and $3.60 from high to low income.
Table A.3: Transfer Calculations
Group Payout Withheld Premium pi/period Sum Zero
Low Inc. Young 21.54 19.43 8.46 -6.34 -4.74
Low Inc. Old 36.51 17.73 8.46 10.32 11.93
High Inc. Young 19.43 23.7 7.9 -12.17 -10.56
High Inc. Old 32.26 22.45 8.05 1.76 3.37
Total 109.75 83.31 32.87 -6.43 0
A.4 Supplemental regressions
Table A.4 report coefficient estimates and level cut points from ordered probit regressing Resilience
on insurance type, as robustness check to the regression on resilience as continuous variable, re-
ported in the main text. Estimates are consistent with the continuous version. In all cases employer
insurance reduces resilience.
A.5 Results summary
All treatment effects, for both optimally computed (DP maximizers) and observed (human sub-
jects), are summarized in the following tables: In both tables, sign denotes direction of effect,
number of signs denotes size of mean effect relative to its range and variation. Blank cells indicate
no meaningful effect. Survival is calculated only for the old. Table A.5 reports difference between
DP joy maximizers and the human subjects.
Table A.6 has three sections. In each section, there is a column for the within DP joy maximizer
comparison and a column for the within human subject (HS) comparison. The top section reports
the differences between the employer and actuarial treatments. The middle section reports the
differences between old and young. The bottom section reports the difference between high and
low income.
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Table A.4: Estimates from ordered probit regressing Resilience on insurance type
(1) (2) (3) (4)
Young Young Old Old
Low Income High Income Low Income High Income
Employer -1.217*** -1.283*** -1.090*** -1.154***
(0.0971) (0.100) (0.110) (0.0861)
/cut1 0.408*** 0.0527 0.181* -0.216***
(0.0579) (0.0770) (0.0940) (0.0799)
/cut2 0.708*** 0.259*** 0.638*** 0.0874
(0.0617) (0.0764) (0.0856) (0.0579)
/cut3 1.232*** 0.662*** 1.148*** 0.606***
(0.0853) (0.0518) (0.0905) (0.0786)
/cut4 1.647*** 1.094*** 1.850*** 1.286***
(0.0954) (0.0575) (0.136) (0.110)
Observations 4,224 4,224 4,096 4,096
Robust standard errors in parentheses
*** p<0.01, ** p<0.05, * p<0.1
Table A.5: Effect Size, (DP Maximizers - Human Subject)
Income Ins. Type Insurance Resilience Health Survival to Total Total Joy
Type Age Purchase Investment Investment period 32 Savings Consumed
Low
Act/Yng + - + +++ +++
Act/Old - - ++ ++ +++ +++ +++
Emp/Yng + + ++
Emp/Old ++ + + ++
High
Act/Yng ++ + +++ ++
Act/Old - - +++ ++ + +++ ++
Emp/Yng - ++ ++
Emp/Old + ++ ++
Legend: sign notes direction. -/+ small but meaningful,- -/ ++ moderate, - - -/+++ large difference
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Table A.6: Effect Size for all Treatment Comparison
Insurance Resilence Health Survival Savings Joy
Purchase
Compare Subgroup DP HS DP HS DP HS DP HS DP HS DP HS
Emp-Act
Yng Low ++ ++ - - + - - - +
Old Low +++ ++ - - - ++ +++ - - - - -
Yng High +++ ++ - - - - - - - - -
Old High +++ ++ - - - + - - - - - - -
Old-Yng
Act Low - - - ++ + - - - - ++ ++
Act High - - + ++ + - - - + +
Emp Low ++ - + +
Emp High ++ + - +
High-
Low
Act Yng - - - - +++ + + + + + +++ +++
Act Old - ++ + + ++ +++ +++ +++
Emp Yng - + + + + - +++ +++
Emp Old - + + + + - + + +++ +++
Legend: sign notes direction. -/+ small but meaningful, - -/ ++ moderate, - - -/+++ large difference
A.6 Decomposition
Moral Hazard and Joy Transfers – Subjects under the Employer treatment (especially Low-
income) were able to perform relatively better, compared to maximizers, than their actuarial coun-
terparts. This indicates that the subsidies and implicit transfers provided under the employer plan,
from high to low-Income and from young to old subjects, are having a marked effect even though all
subjects tend to underinvest in resilience. Because actuarial insurance bases its premiums on indi-
vidual subject resilience and health, there is by definition no moral hazard and no welfare transfers
between categories of actuarial subjects. But considering the degree to which the actuarial subjects
fall ‘behaviorally’ short of optimal resilience investment, we can assume that that employer subjects
underinvesting to any greater extent are falling subject to moral hazard.
The mean percentage by which actuarial subjects underinvest in resilience was 54%. Premiums
in the employer insurance treatment were pre-calibrated to be profitable despite anticipated under-
investment in resilience. To measure subject-induced moral hazard under the employer treatment,
we simply calculated the insurer’s expected profit and the subjects’ expected joy for every level
of health and resilience the subject could have had. We then calculated how much the insurance
company could have transferred to the maximizer/subject conditional on her investing in each re-
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Table A.7: Employer Subjects’ Decomposition of Joy Obtained
Low Income High Income
DP Subjects DP Subjects
Actuarial Joy 2423 1679 3462 2609
Selection Bias 0 0 0 0
Transfer Young→ Old -31 4 -25 1
Transfer High→ Low 99 66 -75 -112
Admin Fees -27 -21 -37 -14
Moral Hazard -80 -57 -96 -63
Health Modified Joy 0 27 0 23
Death Prevention Joy 0 173 0 11
Total Adjustments -39 193 -233 -154
(% Actuarial Joy Obtained) (-1.6%) (+11.5%) (-6.7%) (-5.9%)
Residual Joy -21 -56 -16 27
(% Actuarial Joy Obtained) (0.3%) (-8.2%) (-0.5%) (+4.9%)
Employer Joy 2391 1816 3213 2482
silience level in order for the insurer to have the same expected profit as it does when subjects have
a fitness of 0. Finally, we calculated how much more expected joy the subject could have earned
with the conditional transfer. We defined potential moral hazard costs as the gain in expected joy
between a subject’s optimal resilience level and observed (mean) levels in actuarial subjects. We
then calculated how high expected joy level would have been if there were transfers and the sub-
jects maintained the fitness level that actuarial subjects maintained, which was 46% of the potential
moral hazard cost. The balance, 54% of the transfer benefits, can be attributed to the behavioral
proclivity to underinvest in resilience, even when there are incentives to invest, as in the actuarial
treatment.
Using this information and mean expenditures on the various possible investments, Table A.7
below decomposes the mean components of joy obtained under the employer treatment, relative
to the actuarial treatment, by considering the insurance subsidies provided and received.
The first line of Table A.7 shows the mean joy amounts at the end of life for the each income
group in the actuarial Treatment. The last line shows the corresponding means in the employer
treatment. Each intermediary line is the estimated impact of one difference between treatments.
We saw no selection bias in the employer treatment, neither in the DP nor human subjects, meaning
young and old purchase insurance at near identical rates. The third line reports estimates for the
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benefit of consumption smoothing from the transfers from young to old netted across life. The
human subjects benefit mildly from these. The DP is actually hurt by the transfers. The DP has
the foresight to save to smooth consumption, so the imposed transfers constrain its ability to adjust
savings according to the stochastic shock pattern experienced. The fourth line reports the estimated
impact of the transfers from rich to poor: the effects are strong and all in the correct direction. The
administration fee line is the estimation of the cost in joy to the employer subjects of the profit the
insurer extracts. Moral hazard is the estimated impact on joy of maintaining resilience at a lower
level, which may be individually optimal but socially costly. The Health Modified Joy line is the
estimate of how much higher health in the Employer versus actuarial treatment benefits subjects
by increasing their joy: DP maximizers do not display this effect. The Death Prevention Joy line
is the estimate of how much extended life in the employer versus actuarial treatment benefits
subjects by increasing their joy: again, DP maximizers do not display this effect. The Residual Joy
is the unexplained difference between observed joy in the actuarial and employer treatments after
accounting for the Total Adjustments.
Subjects The young to old transfer was estimated by averaging the consumption across the
young and old periods, and taking the difference between the smoothed and unsmoothed con-
sumption. Admittedly, this is only part of the benefit of the transfer—the amount applied to con-
sumption. The other part is the benefit gained by applying some of the transfer to increasing
health. This is the health modify joy line, which is the difference in the amount of joy actuarial
consumption would have resulted in between employer treatment levels of health and the level in
the actuarial treatment. The rich to poor transfer was calculated by taking the difference between
consumption if was increased by (transfer + mean income)/mean income. Admin was found by the
same method as the previous transfer but with the amount of the increase in profit in the employer
treatment relative to the actuarial. Prevent death is the difference in expected mean joy at the end
of life including or not including subjects who died early.
DP We calculated for the employer subjects net payments to the insurer, summing withholdings
and premium paid less health regenerated from insurance, for each age and income combination.
The administration cost is the adjustment required for the employer plan to have the same profit
as the actuarial plan, $-0.53 per subject per period. For the administration line we reran the DP
adjusting the income each period by this amount. The young to old and low to high transfer lines
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follow the same logic. After adjusting for the difference in administration costs, we found the mean
for age or income and used that amount to adjust the DP’s income. We report the difference in Joy
earned with adjusted and unadjusted income. The Joy Modified income line is not calculated for
the DP, because using method above the DP increases it income so this is already included. The
prevent death line is not calculated because there were no lives under either treatment in which
the DP died prematurely.
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